StockData
InMed Pharmaceuticals Inc. logo

InMed Pharmaceuticals Inc. (MTRI) stock

MTRINasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as INM
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 4/30
$17.50−2.37 (-11.93%)

Close on Nov 17, 2026Market cap $96.14MP/E –Yield –

InMed Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

InMed Pharmaceuticals's market cap was $8.97M on Nov 3, 2026, against $3.46M a year earlier. Over the last 5 years it ranged from $1.12M to $13.53M, with a median of $2.86M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 3, 2026$8.97M+225.0%
2025Dec 31, 2025$2.76M-12.7%
2024Dec 31, 2024$3.16M+128.4%
2023Dec 29, 2023$1.38M-24.6%
2022Dec 30, 2022$1.84M-86.4%
2021Dec 31, 2021$13.53M-21.2%
2020Dec 31, 2020$17.18M–

More InMed Pharmaceuticals figures

See a number that looks wrong?